Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Bone Marrow Transplant ; 53(1): 39-43, 2018 01.
Article in English | MEDLINE | ID: mdl-28991245

ABSTRACT

Hematopoietic cell transplant (HCT) recipients have a substantial risk of developing secondary solid cancers (SSCs). The aim of this retrospective study was to compare the incidence of SSC in a monocentric cohort of thalassemia major (TM) patients (n=122) who received HCT versus an hematopoietic cell donor monocentric cohort (n=122) and versus a large multicenter cohort of age- and sex-matched TM patients (n=244) who received conventional therapy. With a median follow-up of 24 years, 8 transplanted patients were diagnosed with SSC at a median of 18 years after HCT and at a median age of 33 years. Three patients died of cancer progression and 5 are living after a follow-up ranging from 10 months to 16 years after SSC diagnosis. The 30-year cumulative incidence of developing SSC was 13.24%. The occurrence of solid cancers in the hematopoietic cell donor cohort was limited to only one case for a significantly lower cumulative incidence (3.23%, P=0.02) and to 3 cases in the cohort of nontransplant patients for a significantly lower cumulative incidence (1.32%, P=0.005). This study shows that the magnitude of increased risk of SST is fourfold to sixfold for patients treated with HCT as compared with hematopoietic cell donors and nontransplant patients.


Subject(s)
Hematopoietic Stem Cell Transplantation/adverse effects , Neoplasms, Second Primary/etiology , Transplantation Conditioning/adverse effects , beta-Thalassemia/complications , Female , Humans , Male , Middle Aged , Neoplasms, Second Primary/pathology
2.
Minerva Anestesiol ; 78(12): 1357-64, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22858878

ABSTRACT

BACKGROUND: Thrombelastography (TEG) provides an effective and convenient means of whole blood coagulation monitoring. TEG evaluates the elastic properties of whole blood and provides a global assessment of hemostatic function. Previous studies performed TEG on native blood sample, but no data are available with citrated samples in healthy pregnant women at term. The aim of this study was to investigate the effect of pregnancy on coagulation assessed by TEG and establish normal ranges of TEG values in pregnant women at term comparing them with healthy non pregnant young women. METHODS: We enrolled pregnant women at term undergoing elective cesarean section or labour induction (PREG group) and healthy non-pregnant women (CTRL group). Women with fever or inflammatory syndrome, defined as C-reactive protein (CRP) >5 mg/L and with a platelet count <150.000/mm(3) have been excluded. For each women hemochrome and standard coagulation test were assessed. At the same time we performed a thrombelastographic test with Hemoscope TEG(®) after sample recalcification without using any activator. RESULTS: One hundred thirty patients were studied, 65 for each group. There were no differences between groups regarding demographic data. Hemoglobin, platelet count, International Normalized Ratio and Activated Partial Thromboplastin Time Ratio were lower and fibrinogen was higher in PREG group. All TEG parameters resulted as being significantly different between the groups with a hypercoagulable pattern in PREG group compared to CTRL group. CONCLUSION: The main findings of this study confirm the hypercoagulability status of pregnant women at term. This coagulation pattern is well represented by thrombelastographic trace obtained by recalcified citrate blood sample.


Subject(s)
Blood Coagulation Tests/methods , Citrates/chemistry , Pregnancy/blood , Thrombelastography/methods , Adult , Female , Fibrin Clot Lysis Time , Fibrinogen/analysis , Humans , International Normalized Ratio , Partial Thromboplastin Time
3.
Heart ; 95(20): 1688-93, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19491092

ABSTRACT

BACKGROUND: Cardiovascular magnetic resonance (CMR) by delayed enhancement (DE) enables visualisation of myocardial scarring, but no dedicated studies are available in thalassaemia major. OBJECTIVE: To investigate the prevalence, extent, clinical and instrumental correlates of myocardial fibrosis or necrosis by DE CMR in patients with thalassaemia major. PATIENTS: 115 Patients with thalassaemia major consecutively examined at an MRI laboratory. METHODS: DE images were acquired to quantify myocardial scarring. Myocardial iron overload was determined by multislice multiecho T2*. Cine images were obtained to evaluate biventricular function. RESULTS: DE areas were present in 28/115 patients (24%). The mean (SD) extent of DE was 3.9 (2.4)%. In 26 patients the location of fibrosis was not specific and patchy distribution was prevalent. Two patients showed transmural DE following coronary distribution. The DE group was significantly older than the no-DE group (31 (7.7) years vs 26 (7.7) years, p = 0.004). No significant relation with heart T2* values and biventricular function was found. A significant correlation was found between the presence of DE and changes in ECG (ECG abnormal in the DE group 22/28 patients and in the no-DE group 30/87 patients; chi(2) = 14.9; p<0.001). CONCLUSIONS: In patients with thalassaemia the significant presence of myocardial fibrosis/necrosis seems to be a time-dependent process correlating with cardiovascular risk factors and cardiac complications. Levels of HCV antibodies are significantly higher in the serum of patients with thalassaemia with myocardial fibrosis/necrosis. ECG changes showed a good accuracy in predicting myocardial scarring.


Subject(s)
Cicatrix/pathology , Myocardium/pathology , beta-Thalassemia/pathology , Adult , Female , Humans , Iron Overload/pathology , Magnetic Resonance Angiography/methods , Magnetic Resonance Imaging, Cine , Male , Necrosis/pathology , Retrospective Studies
4.
Minerva Anestesiol ; 73(1-2): 13-21, 2007.
Article in English | MEDLINE | ID: mdl-17159764

ABSTRACT

AIM: We compared spinal anesthesia and sciatic-femoral block for arthroscopic knee surgery in terms of hemodynamic changes, intraoperative anesthesia, postoperative analgesia, postoperative motor block and bladder function, side effects, and patient satisfaction. METHODS: Thirty-two patients were randomised into 2 groups: Group B (sciatic-femoral block with mepivacaine 1% 15 + 25 mL, 120 mm/35 mm 22-gauge needles and ElectroNerve Stimulator) and Group S (unilateral spinal anesthesia with 7 mg of hyperbaric bupivacaine 0.5% and 25-gauge Sprotte needle in L2-L3 space). We recorded pain, together with hemodynamic parameters (baseline, 5, 10, 15, 30 min), utilising Numerical Rating Scale (NRS) during the tourniquet application and during the surgical procedures, anesthesia quality, orthopedic evaluation for intraoperative liberty of knee movement. During the postoperative period we recorded at 2, 4 and 6 h: postoperative analgesia, motor block, first urine output, side effects, first requirement for analgesic drug, patient satisfaction and costs. RESULTS: The only significant differences between the 2 groups (P<0.05) were the heart rate changes at 10, 15, 30 min with an increase in Group B and a decrease in Group S, and the first urine output at 200+/-69 min in Group B versus 269+/-66 min in Group S. CONCLUSION: In conclusion the sciatic-femoral nerve block is a valid alternative to spinal anesthesia for arthroscopic knee surgery, leading to a faster discharging from the hospital.


Subject(s)
Anesthesia, Spinal , Arthroscopy , Femoral Nerve , Knee/surgery , Nerve Block , Sciatic Nerve , Adult , Anesthesia, Spinal/adverse effects , Blood Pressure/physiology , Female , Heart Rate/physiology , Humans , Male , Middle Aged , Nerve Block/adverse effects , Pain Measurement , Pain, Postoperative/epidemiology
5.
Anesth Analg ; 91(3): 727-31, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10960408

ABSTRACT

UNLABELLED: We evaluated the effects of tourniquet application on the cardiovascular system and metabolism in 10 young men undergoing knee surgery with general anesthesia. The duration of inflation was from 75 to 108 min. Heart rate, mean arterial pressure, cardiac index (CI) by pulse contour method, and systemic vascular resistance were measured before, during, and after tourniquet inflation. pH, PaO(2), PaCO(2), and lactate blood concentrations were also measured. VO(2) and VCO(2) were assessed every minute from tracheal intubation up to 15 min after tourniquet deflation and VO(2) in excess of the basal value over the 15 min after deflation (VO(2)exc) was calculated. Mean arterial pressure increased 26% (P: < 0.05) during inflation and returned to basal values after deflation. CI did not change immediately after inflation; although, thereafter, it increased 18% (P: < 0.05). Five minutes after deflation, CI further increased to a value 40% higher than the basal value. Therefore, systemic vascular resistance increased 20% suddenly after inflation (P: < 0.05) and decreased 18% after deflation (P: < 0.05). VO(2) and VCO(2) remained stable during inflation and increased (P: < 0.05) after deflation. VO(2)exc depended on duration of tourniquet inflation time (Tisch) (P: < 0.05). After deflation, PaCO(2) and lactate increased (P: < 0.05) while Tisch increased. We conclude that tourniquet application induces modifications of the cardiovascular system and metabolism, which depend on tourniquet phase and on Tisch. Whether these modifications could be relevant in patients with poor physical conditions is not known. IMPLICATIONS: The clinical effects of tourniquet application were evaluated in 10 young men undergoing knee surgery. Our data indicate that tourniquet application causes hemodynamic and metabolic changes which may become clinically relevant after a long period of tourniquet inflation, particularly in patients with concomitant cardiovascular diseases.


Subject(s)
Hemodynamics/physiology , Knee/surgery , Metabolism/physiology , Tourniquets/adverse effects , Adolescent , Adult , Anesthesia, General , Anterior Cruciate Ligament/surgery , Blood Pressure/physiology , Carbon Dioxide/blood , Cardiac Output/drug effects , Humans , Male , Oxygen Consumption/physiology
6.
Ann Hematol ; 78(11): 521-3, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10602896

ABSTRACT

Vincristine (1.4 mg/m(2) on day 1, followed by 1 mg on days 4 and 7) was given to eight patients with thrombotic thrombocytopenic purpura (TTP) who were refractory to plasma exchange (n=4) or plasma infusion (n=4). Seven of eight patients (87%) achieved a complete response; one was refractory to treatment and died within a few weeks. After a median follow-up of 50 months, all responding patients are alive and well. Two patients relapsed and were successfully retreated with vincristine. Toxicity was mild, consisting of two episodes of leukopenia and one of autonomic neuropathy leading to paralytic ileus in a patient aged 70 years. We conclude that vincristine is highly effective in the treatment of patients suffering from refractory TTP, with negligible toxicity.


Subject(s)
Purpura, Thrombotic Thrombocytopenic/drug therapy , Vincristine/therapeutic use , Adult , Aged , Female , Humans , Male , Middle Aged , Remission Induction , Salvage Therapy , Time Factors
7.
Ann Hematol ; 78(2): 87-8, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10089024

ABSTRACT

We describe a case of stable complete remission in a patient with refractory anemia complicated by severe autoimmune hemolytic anemia, achieved with a single high dose (4 g/m2) of cyclophosphamide (cyclo). Concomitantly, an effective mobilization of CD34-positive cells was induced. Other immunosuppressive approaches including high-dose methylprednisolone, high-dose immunoglobulin, and cyclosporine had been ineffective. This finding suggests that, in selected cases, an immunologic mechanism may mediate cytopenia in myelodysplastic syndromes (MDS). In addition, it demonstrates that successful mobilization of peripheral blood stem cells can be induced with high-dose cyclo in MDS.


Subject(s)
Anemia, Refractory/drug therapy , Autoimmune Diseases/drug therapy , Cyclophosphamide/therapeutic use , Immunosuppressive Agents/therapeutic use , Adult , Anemia, Hemolytic, Autoimmune/complications , Anemia, Hemolytic, Autoimmune/drug therapy , Anemia, Hemolytic, Autoimmune/pathology , Anemia, Hemolytic, Autoimmune/therapy , Anemia, Refractory/complications , Anemia, Refractory/pathology , Anemia, Refractory/therapy , Autoimmune Diseases/complications , Autoimmune Diseases/pathology , Autoimmune Diseases/therapy , Blood Transfusion , Bone Marrow/pathology , Cyclophosphamide/administration & dosage , Cyclosporine/therapeutic use , Hematopoietic Stem Cell Mobilization , Humans , Immunoglobulins, Intravenous/therapeutic use , Immunosuppressive Agents/administration & dosage , Male , Methylprednisolone/therapeutic use , Remission Induction
8.
Gene ; 175(1-2): 1-5, 1996 Oct 10.
Article in English | MEDLINE | ID: mdl-8917068

ABSTRACT

Neuropeptides are the key molecules in a multiplicity of physiological processes and their use in pest control has recently been suggested. Most neuropeptides are produced in the form of a precursor that is cleaved by proteolysis to yield various biologically active peptides. To mimic this structure, a method has been developed for synthesizing genes that code for putative polyneuropeptide precursors. As a model neuropeptide, the 5-amino-acid proctolin, one of the best studied invertebrate neuropeptides, functioning both as a visceral and a skeletal neuromuscular transmitter, was chosen. The synthetic gene was introduced into bacteria and tobacco plants, where it was efficiently transcribed. We present our results as a possible approach for the expression, in a variety of organisms, of synthetic genes coding for a wide repertoire of insect neuropeptides.


Subject(s)
Genes, Protozoan/genetics , Insect Control/methods , Neuropeptides/genetics , Nicotiana/genetics , Oligopeptides/genetics , Plants, Toxic , Protein Engineering/methods , Protein Precursors/genetics , Transfection/methods , Amino Acid Sequence , Genetic Vectors/genetics , Molecular Sequence Data , Neuropeptides/metabolism , Oligopeptides/metabolism , Protein Precursors/metabolism , Nicotiana/metabolism
9.
Chir Ital ; 47(6): 26-9, 1995.
Article in Italian | MEDLINE | ID: mdl-9480190

ABSTRACT

Epidural analgesia with local anesthetics and opioids is one of the most effective methods for postoperative pain control. In critical patients it seems to improve outcome as well as pain control. This technique works better when started in the intraoperative time. Epidural analgesia is safe on surgical wards if nursing staff is trained in managing epidural catheters and in early detection and treatment of major and minor side effects. Nursing staff cooperates with the Acute Pain Service doctors and nurses who are on call on a 24 hour basis. Many perspective and retrospective studies showed a very low incidence of major side effects with epidurals. So we can consider it safe and effective even if we consider its invasiveness.


Subject(s)
Analgesia, Epidural , Pain, Postoperative/drug therapy , Analgesia, Epidural/adverse effects , Analgesia, Epidural/methods , Analgesia, Patient-Controlled , Humans , Intraoperative Care , Prospective Studies , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...